O-004: HBV RNA in serum is an early predictor for sustained immune control following treatment with pegylated interferon alfa in patients with HBeAg negative chronic hepatitis B and its relation to other serum viral biomarkers

2018 ◽  
Vol 25 ◽  
pp. 7-7
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Pegylated Interferon ◽  
Interferon Alfa ◽  
Immune Control ◽  
Pegylated Interferon Alfa ◽  
Negative Chronic Hepatitis ◽  
Early Predictor

scholarly journals Pegylated Interferon Alfa-2b Monotherapy and Pegylated Interferon Alfa-2b plus Lamivudine Combination Therapy for Patients with Hepatitis B Virus E Antigen-Negative Chronic Hepatitis B

2007 ◽  
Vol 51 (8) ◽  
pp. 3020-3022 ◽  
Author(s):  
Sabahattin Kaymakoglu ◽  
Dilek Oguz ◽  
Gurden Gur ◽  
Selim Gurel ◽  
Ethem Tankurt ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Combination Therapy ◽  
Chronic Hepatitis B ◽  
Pegylated Interferon ◽  
Interferon Alfa ◽  
B Virus ◽  
Pegylated Interferon Alfa ◽  
Negative Chronic Hepatitis

ABSTRACT Forty-eight hepatitis B virus (HBV) E antigen-negative chronic hepatitis B patients received pegylated interferon alfa-2b either alone or with lamivudine for 48 weeks and were followed for an additional 24 weeks. At the end of follow-up, virological response rates (HBV DNA levels of <400 copies/ml) were similar in the monotherapy (24%) and combination therapy (26%) groups.

scholarly journals Impact of Pegylated Interferon-alfa-2a on Perforin Level in Patients With Chronic Hepatitis B; Preliminary Study

2013 ◽  
Vol 13 (11) ◽  
Author(s):  
Meisam Mahdavi ◽  
Houshang Amirrasouli ◽  
Seyed Moayed Alavian ◽  
Bita Behnava ◽  
Faranak Kazerouni ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis B ◽  
Chronic Hepatitis B ◽  
Pegylated Interferon ◽  
Interferon Alfa ◽  
Pegylated Interferon Alfa ◽  
Preliminary Study
Sign in / Sign up

Export Citation Format

Share Document